Drug recall D-0096-2017

Class II Terminated reported Oct 19, 2016

Product

Marcaine 0.25% (bupivacaine HCl) injection, USP, 125 mg/50 mL (2.5 mg/mL), 50 mL Multiple-Dose Vial, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-1587-50.

Reason for recall

Lack of Assurance of Sterility and Subpotent Drug: defect in glass vial prevented stopper from forming a seal allowing water to ingress and dilute the product causing it to be less than the labeled potency.

Lots and codes

Lot #: 60295DD, Ep 1DEC2017

Recall details

Recalling firm
Hospira Inc., A Pfizer Company, Lake Forest, IL
Quantity
15 vials
Distribution
Nationwide and Puerto Rico
Type
Voluntary: Firm initiated
Recall initiated
September 16, 2016
Terminated
July 31, 2019

Related products